Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07561372 · ClinicalTrials.gov registry record · NA

Adaptive Recruitment Curve Analysis Using Bayesian Modeling

A NA study, sponsored by Columbia University.

Not yet
Registry status
NA
Development phase
10
Enrollment target

NCT07561372: Clinical Trial NA study, sponsored by Columbia University.

NCT07561372 is a NA study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07561372, a NA study, has not yet begun recruiting, sponsored by Columbia University.

NOT YET RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to better understand how electrical or magnetic stimulation affect the nervous system by optimizing the way researchers measure muscle responses. The relationship between stimulation intensity and muscle response is described by "neural recruitment curves," which are critical for monitoring the state of the nervous system during therapies like transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS). This study tests a new, real-time computational approach based on our previously developed methods (Hierarchical Bayesian models) to estimate these recruitment curves more efficiently. The primary goal is to use this model to dynamically guide the experiment, automatically selecting the optimal stimulation intensities to test. The investigators hypothesize that this optimized approach will accurately estimate the entire recruitment curve, or specific targets components of it like the motor threshold, using significantly fewer samples than standard methods. By reducing the number of measurements required, this approach aims to decrease experimental time and minimize participant burden, making future TMS and SCS therapies and experiments more feasible and efficient.

Primary Outcome

Number of stimuli required for the compared methods to reach a pre-defined error threshold relative to the ground truth, computed from recruitment curves fitted after sampling using aggregated data.

Interventions

  • OTHER Algorithm: Uniform Sampling
  • OTHER Algorithm: hbMEP-adaptive algorithm (version 1)
  • OTHER Algorithm: hbMEP-adaptive algorithm (version 2)
  • OTHER ML-PEST
  • DEVICE MagPro X100 Transcranial Magnetic Stimulation

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-08-01
Est. Completion 2027-03-31
Phase NA
Columbia University

958 total trials

What is known before NCT07561372 opens enrollment

NCT07561372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 5 interventions - of which Algorithm: Uniform Sampling is the first listed.

NCT07561372 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07561372 about?

NCT07561372 is a clinical study titled "Adaptive Recruitment Curve Analysis Using Bayesian Modeling". The purpose of this study is to better understand how electrical or magnetic stimulation affect the nervous system by optimizing the way researchers measure muscle responses. The relationship between stimulation intensity and muscle response is described by "neural recruitment curves," which are cri...

What is the current status of trial NCT07561372?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-08-01. Estimated completion is 2027-03-31.

What interventions are being tested in trial NCT07561372?

The interventions under investigation include: Algorithm: Uniform Sampling (OTHER), Algorithm: hbMEP-adaptive algorithm (version 1) (OTHER), Algorithm: hbMEP-adaptive algorithm (version 2) (OTHER), ML-PEST (OTHER), MagPro X100 Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07561372?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07561372's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07561372, the US trial registry maintained by the National Library of Medicine. NCT07561372 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.